rs114759170

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS2

The NM_000159.4(GCDH):​c.1085C>A​(p.Ala362Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000888 in 1,614,112 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A362V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0042 ( 4 hom., cov: 31)
Exomes 𝑓: 0.00054 ( 3 hom. )

Consequence

GCDH
NM_000159.4 missense, splice_region

Scores

2
6
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.28

Publications

4 publications found
Variant links:
Genes affected
GCDH (HGNC:4189): (glutaryl-CoA dehydrogenase) The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013]
GCDH Gene-Disease associations (from GenCC):
  • glutaryl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_000159.4
BP4
Computational evidence support a benign effect (MetaRNN=0.009075999).
BP6
Variant 19-12897705-C-A is Benign according to our data. Variant chr19-12897705-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 459946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GCDHNM_000159.4 linkc.1085C>A p.Ala362Asp missense_variant, splice_region_variant Exon 11 of 12 ENST00000222214.10 NP_000150.1
GCDHNM_013976.5 linkc.1085C>A p.Ala362Asp missense_variant, splice_region_variant Exon 11 of 12 NP_039663.1
GCDHNR_102316.1 linkn.1248C>A splice_region_variant, non_coding_transcript_exon_variant Exon 11 of 12
GCDHNR_102317.1 linkn.1466C>A splice_region_variant, non_coding_transcript_exon_variant Exon 10 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GCDHENST00000222214.10 linkc.1085C>A p.Ala362Asp missense_variant, splice_region_variant Exon 11 of 12 1 NM_000159.4 ENSP00000222214.4 Q92947-1

Frequencies

GnomAD3 genomes
AF:
0.00423
AC:
643
AN:
152134
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0144
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00119
AC:
298
AN:
251392
AF XY:
0.00104
show subpopulations
Gnomad AFR exome
AF:
0.0129
Gnomad AMR exome
AF:
0.00168
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000237
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000539
AC:
788
AN:
1461860
Hom.:
3
Cov.:
32
AF XY:
0.000479
AC XY:
348
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0149
AC:
499
AN:
33476
American (AMR)
AF:
0.00163
AC:
73
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53408
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.000125
AC:
139
AN:
1111994
Other (OTH)
AF:
0.00106
AC:
64
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
48
96
143
191
239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00424
AC:
645
AN:
152252
Hom.:
4
Cov.:
31
AF XY:
0.00419
AC XY:
312
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0144
AC:
600
AN:
41534
American (AMR)
AF:
0.00131
AC:
20
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68012
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00160
Hom.:
3
Bravo
AF:
0.00487
ESP6500AA
AF:
0.0116
AC:
51
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00139
AC:
169
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glutaric aciduria, type 1 Benign:3
Dec 12, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Aug 11, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

GCDH-related disorder Benign:1
Mar 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.88
D;D
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.26
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
.;D
MetaRNN
Benign
0.0091
T;T
MetaSVM
Uncertain
0.036
D
MutationAssessor
Benign
1.7
L;L
PhyloP100
2.3
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-2.5
N;.
REVEL
Uncertain
0.34
Sift
Benign
0.090
T;.
Sift4G
Benign
0.20
T;T
Polyphen
0.0010
B;B
Vest4
0.37
MVP
0.92
MPC
0.58
ClinPred
0.0083
T
GERP RS
2.2
PromoterAI
-0.018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.55
gMVP
0.97
Mutation Taster
=50/50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114759170; hg19: chr19-13008519; API